Kaletra (lopinavir/ritonavir) Product Label Update
|
|
|
FDA News
Kaletra (lopinavir/ritonavir) Product Label Update |
|
May 23, 2007 =Product labeling
for
KALETRA (lopinavir/ritonavir)
has been updated
to
reflect safety and efficacy data from study M97-720 in treatment-naïve patients out to 360 weeks. Kaletra is manufactured by Abbott Laboratories, North Chicago, IL. The complete revised product labeling is provided in the pdf attached file  Richard Klein Office of Special Health Issues Food and Drug Administration Kimberly Struble Division of Antiviral Drug Products Food and Drug Administration |
|
Kaletra (lopinavir/ritonavir) Product Label Update |
|
Medical Advocates |
